COSTING AND FUNDING OF HEALTH-CARE IN AUSTRALIA - PHARMACEUTICALS IN CONTEXT

[1] Deebie J., Medical services through Medicare, National Health Strategy Background Paper No. 2, Australian Government Printing Services, (1991)

[2] Henry D., Economic analysis as an aid to subsidisation: the development of Australian guidelines for pharmaceuticals, PharmacoEconomics, 1, pp. 54-67, (1992)

[3] Koopmanship M.A., Ruiten F.F.H., Indirect costs in economic studies: confronting the confusion, PharmacoEconomics, 4, 6, pp. 446-454, (1993)

[4] Macklin J., The National Health Strategy: setting the agenda for change, National Health Strategy Background Paper No. 1, Australian Government Printing Service, (1990)

[5] Parry T.G., Creyke P., The Australian pharmaceutical industry: achievements, prospects and the policy environment, Australian Pharmaceutical Manufacturers Association, (1991)

[1] Deebie J., Medical services through Medicare, National Health Strategy Background Paper No. 2, Australian Government Printing Services, (1991)

[2] Henry D., Economic analysis as an aid to subsidisation: the development of Australian guidelines for pharmaceuticals, PharmacoEconomics, 1, pp. 54-67, (1992)

[3] Koopmanship M.A., Ruiten F.F.H., Indirect costs in economic studies: confronting the confusion, PharmacoEconomics, 4, 6, pp. 446-454, (1993)

[4] Macklin J., The National Health Strategy: setting the agenda for change, National Health Strategy Background Paper No. 1, Australian Government Printing Service, (1990)

[5] Parry T.G., Creyke P., The Australian pharmaceutical industry: achievements, prospects and the policy environment, Australian Pharmaceutical Manufacturers Association, (1991)